Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,252 | 99,734 | 84,205 | 98,867 | 66,216 |
| Marketable Securities | 717 | 958 | 912 | 1,165 | 1,221 |
| Inventories | 673 | N/A | 283 | N/A | N/A |
| TOTAL | $80,609 | $107,685 | $92,565 | $101,376 | $68,414 |
| Non-Current Assets | |||||
| PPE Net | 1,335 | 1,902 | 1,751 | 1,594 | 1,617 |
| Investments And Advances | 13,898 | 0 | 0 | 0 | 0 |
| Intangibles | 18,192 | 18,350 | 18,785 | 17,110 | 17,458 |
| Other Non-Current Assets | 3,056 | 3,124 | 310 | 228 | 222 |
| TOTAL | $36,481 | $23,376 | $20,846 | $18,933 | $19,297 |
| Total Assets | $117,090 | $131,060 | $113,411 | $120,309 | $87,711 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,322 | 1,383 | 968 | 4,621 | 2,090 |
| Accrued Expenses | 2,361 | 2,121 | 1,406 | 801 | 545 |
| TOTAL | $6,183 | $5,004 | $3,873 | $6,921 | $2,635 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,499 |
| Other Non-Current Liabilities | 21,650 | 21,843 | 74 | 67 | 55 |
| TOTAL | $21,870 | $21,860 | $74 | $67 | $1,554 |
| Total Liabilities | $28,053 | $26,864 | $3,947 | $6,987 | $4,189 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,572 | 9,572 | 9,572 | 9,359 | 8,659 |
| Common Shares | 958 | 958 | 954 | 1,935 | 923 |
| Retained earnings | -502,428 | -487,115 | -478,941 | -469,677 | -460,920 |
| Other shareholders' equity | -2,061 | -949 | -1,261 | -1,259 | -574 |
| TOTAL | $89,038 | $104,196 | $109,464 | $113,321 | $83,522 |
| Total Liabilities And Equity | $117,090 | $131,060 | $113,411 | $120,309 | $87,711 |